These should be glorious days for an unfortunate creature known as the OncoMouse. In the mid-1980s, Harvard researchers learned to insert cancer-causing genes, known as oncogenes, into a mouse, making ...
"The focus of this case is a very small animal, namely a mouse - to use a poet's description, a 'Wee, sleekit, cowrin, tim'rous beastie' (R Burns, "To a Mouse", 1785). In all other respects however, ...
The European Patent Office (EPO) has approved a restricted patent on the Harvard OncoMouse, dealing a setback to activists who fought for 9 years to bar EU patents on living organisms. The EPO on July ...
The European Patent Office (EPO) granted the Oncomouse patent to DuPont in 1992, despite opposition by animal rights groups who charged it was cruel to engineer an animal to die a painful death. The ...
The online database categorizing collections of the Smithsonian Institution contained, as of a few weeks ago, 10,210,050 objects and documents, of which 230,590 (or around 2.25 percent) answered to ...
Caliper Discovery Alliances & Services (CDAS), which offers multiple tumor models for preclinical cancer research, reports that it recently developed a pancreatic OncoMouse® model—EL1-luc/EL1-SV40 ...
The Canadian Supreme Court has turned down a far-reaching patent application on a genetically modified mouse — setting Canada's intellectual property law on a strikingly independent path. Harvard ...
The 'Harvard OncoMouse' patent (EP 0,169,672) has been further restricted, after several organizations appealed a March 2003 European Patent Office (EPO) decision to allow the patent to apply to all ...
Taconic, has announced that it has entered into an agreement to gain access to the DuPont Intellectual Assets & Licensing OncoMouse® (Wilmington, Delaware) technology. Taconic will employ the DuPont™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback